Patents by Inventor Michael Goldbiatt

Michael Goldbiatt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-TSG101 antibodies and their uses for treatment of viral infections
    Patent number: 8796423
    Abstract: The present invention provides antibodies that bind to the C-terminal region of TSG101. The invention also provides methods of using the TSG101 antibodies for the treatment of viral infections, including HIV and Ebola virus infection.
    Type: Grant
    Filed: April 18, 2008
    Date of Patent: August 5, 2014
    Assignee: Eli Lilly and Company
    Inventors: Limin Li, Michael Kinch, Michael Goldbiatt
  • ANTI-TSG101 ANTIBODIES AND THEIR USES FOR TREATMENT OF VIRAL INFECTIONS
    Publication number: 20090186041
    Abstract: The present invention provides antibodies that bind to the C-terminal region of TSG101. The invention also provides methods of using the TSG101 antibodies for the treatment of viral infections, including HIV and Ebola virus infection.
    Type: Application
    Filed: April 18, 2008
    Publication date: July 23, 2009
    Applicant: Functional Genetics, Inc.
    Inventors: LIMIN LI, Michael Kinch, Michael Goldbiatt